Optimization of the Flare Management in Rheumatoid Arthritis (RA) by Implementing Patient-driven Systematic Changes to the RA Ambulatory Care Stream

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Patient must be ≥ 18 years of age.

• Patient must have been seen by a rheumatology health care provider at least two times within the last 18 months at Mayo Clinic Rochester.

• Patient must have rheumatoid arthritis (RA) according to the 2010 ACR/EULAR classification criteria.

• Patient must have the ability to understand and the willingness to sign a written informed consent document.

• Patient must be willing to return to Mayo Clinic Rochester for follow-up appointments and fill out questionnaires as outlined in the study.

Locations
United States
Minnesota
Mayo Clinic in Rochester
Rochester
Time Frame
Start Date: March 2015
Completion Date: July 1, 2020
Participants
Target number of participants: 178
Treatments
Other: FLARE Intervention Group
In the FLARE Intervention Group, we ask that you participate in all of the following, over the course of two years:~Baseline Study Visit~Monthly: Complete FLARE Questionnaires, at home, and report results. The last question on this questionnaire will ask you if you feel you are having a flare of your disease.~FLARE Study Visit (if applicable): We will schedule you to be seen when/if you feel you are having a flare of your disease.~Follow-up Visits (minimum of every 6 months): These are done as the standard of care for your RA.~At one time-point, during your first return visit after the baseline visit you will have an examination by ultrasound~Patient Satisfaction Surveys at three time-points: Baseline, 1 year, 2 year~Also, your rheumatology health care provider (RHCP) will be asked to participate in the study by completing three satisfaction surveys over the course of two years.
No Intervention: Standard of Care (SOC) Group
If you are randomized to the SOC Group, your care will not be any different than your usual care of rheumatoid arthritis (RA). You will be seen by a rheumatologist at a minimum of every six months, which is the standard of care for RA.~Additionally (for research), we ask the following of you...~At one time-point, during your first return visit after the baseline visit you will have an examination by ultrasound~Patient Satisfaction Surveys at three time-points: Baseline, 1 year, 2 year~Also, your rheumatology health care provider (RHCP) will be asked to participate in the study by completing three satisfaction surveys over the course of two years.
Related Therapeutic Areas
Sponsors
Collaborators: Pfizer
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov

Similar Clinical Trials